Study Summary
This trial sought to find out if the TASK III intervention could reduce the burden on caregivers of stroke survivors.
Eligible Conditions
- Stroke
- Family Caregivers
Treatment Effectiveness
Effectiveness Progress
Study Objectives
1 Primary · 7 Secondary · Reporting Duration: Baseline to 8 weeks (shortterm), baseline to 12, 24, and 52 weeks (long-term)
12 weeks
Program Evaluation Outcomes: Satisfaction
Program Evaluation Outcomes: Technology
Week 52
Life Changes
Week 52
Depressive Symptoms
Healthcare Utilization
Mediator: Self-efficacy of Diet
Mediator: Self-efficacy of Exercise
Mediator: Task Difficulty
Mediator: Threat Appraisal
Other Symptoms
Self-management of Diet
Self-management of Exercise
Self-management of Steps
Unhealthy Days
Trial Safety
Trial Design
2 Treatment Groups
ISR Group
1 of 2
TASK III Group
1 of 2
Active Control
Experimental Treatment
296 Total Participants · 2 Treatment Groups
Primary Treatment: Telehealth Assessment and Skill-Building Kit (TASK III) Group · No Placebo Group · N/A
TASK III Group
Behavioral
Experimental Group · 1 Intervention: Telehealth Assessment and Skill-Building Kit (TASK III) Group · Intervention Types: BehavioralISR Group
Behavioral
ActiveComparator Group · 1 Intervention: Information Support and Referral (ISR) Group · Intervention Types: BehavioralTrial Logistics
Trial Timeline
Screening: ~3 weeks
Treatment: Varies
Reporting: baseline to 8 weeks (shortterm), baseline to 12, 24, and 52 weeks (long-term)
Who is running the clinical trial?
National Institute of Nursing Research (NINR)NIH
529 Previous Clinical Trials
10,287,273 Total Patients Enrolled
14 Trials studying Stroke
6,818 Patients Enrolled for Stroke
University of CincinnatiLead Sponsor
389 Previous Clinical Trials
635,443 Total Patients Enrolled
26 Trials studying Stroke
13,439 Patients Enrolled for Stroke
Tamilyn Bakas, PhD, RNPrincipal InvestigatorUniversity of Cincinnati
1 Previous Clinical Trials
74 Total Patients Enrolled
1 Trials studying Stroke
74 Patients Enrolled for Stroke
Eligibility Criteria
Age 18+ · All Participants · 6 Total Inclusion Criteria
Mark “Yes” if the following statements are true for you:You have no hearing or speech difficulties.\n
You have a score of 4 or more on a 6-item cognitive impairment screener.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top
Conditions
Cancer Related
Treatments